Bristlecone Advisors, LLC Novartis Ag Transaction History

Bristlecone Advisors, LLC

$1.24 Billion
Q3 2024

A detailed history of Bristlecone Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 1,787 shares of NVS stock, worth $175,751. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,787

Previous 2,755 35.14%

Holding current value

$175,751

Previous $293,000 30.03%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$106.13 - $120.89 $102,733 - $117,021	-968 Reduced 35.14%	1,787 $205,000
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $640 - $742	-8 Reduced 0.29%	2,755 $253,000
Q2 2021 Jul 21, 2021	SELL	$85.24 - $94.15 $1.59 Million - $1.75 Million	-18,630 Reduced 87.08%	2,763 $252,000
Q1 2021 Apr 30, 2021	SELL	$83.5 - $98.47 $251,335 - $296,394	-3,010 Reduced 12.33%	21,393 $1.83 Million
Q4 2020 Jan 25, 2021	BUY	$78.07 - $94.43 $12,491 - $15,108	160 Added 0.66%	24,403 $2.3 Million
Q3 2020 Oct 20, 2020	SELL	$82.14 - $91.0 $620,485 - $687,414	-7,554 Reduced 23.76%	24,243 $2.11 Million
Q2 2020 Jul 16, 2020	SELL	$80.93 - $91.1 $7,688 - $8,654	-95 Reduced 0.3%	31,797 $2.78 Million
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $52,649 - $73,762	-745 Reduced 2.28%	31,892 $2.63 Million
Q4 2019 Jan 21, 2020	BUY	$84.35 - $95.37 $97,761 - $110,533	1,159 Added 3.68%	32,637 $3.09 Million
Q3 2019 Oct 28, 2019	SELL	$85.54 - $94.26 $61,930 - $68,244	-724 Reduced 2.25%	31,478 $2.74 Million
Q2 2019 Jul 19, 2019	SELL	$75.4 - $92.8 $117,624 - $144,768	-1,560 Reduced 4.62%	32,202 $2.94 Million
Q1 2019 Apr 23, 2019	BUY	$75.32 - $86.15 $30,429 - $34,804	404 Added 1.21%	33,762 $3.25 Million
Q4 2018 Jan 15, 2019	SELL	$73.66 - $82.02 $11,785 - $13,123	-160 Reduced 0.48%	33,358 $2.86 Million
Q3 2018 Oct 22, 2018	BUY	$66.94 - $77.43 $966,948 - $1.12 Million	14,445 Added 75.74%	33,518 $2.89 Million
Q2 2018 Jul 31, 2018	SELL	$64.91 - $73.36 $180,384 - $203,867	-2,779 Reduced 12.72%	19,073 $1.44 Million
Q1 2018 Apr 24, 2018	SELL	$70.39 - $84.15 $639,985 - $765,091	-9,092 Reduced 29.38%	21,852 $1.77 Million
Q4 2017 Jan 30, 2018	BUY	$72.33 - $77.64 $2,531 - $2,717	35 Added 0.11%	30,944 $2.6 Million
Q3 2017 Oct 20, 2017	BUY	$74.14 - $77.27 $2.29 Million - $2.39 Million	30,909	30,909 $2.65 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Novartis Ag Transaction History